| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial
|
Moulder, Stacy
|
|
2009
|
119 |
3 |
p. 663-671
|
artikel
|
| 2 |
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?
|
Park, Yeon Hee
|
|
2009
|
119 |
3 |
p. 653-661
|
artikel
|
| 3 |
Association of interleukin-10 gene variation with breast cancer prognosis
|
Gerger, Armin
|
|
2009
|
119 |
3 |
p. 701-705
|
artikel
|
| 4 |
A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer
|
McCaig, Fiona M.
|
|
2009
|
119 |
3 |
p. 643-651
|
artikel
|
| 5 |
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
|
Wiedermann, Ursula
|
|
2009
|
119 |
3 |
p. 673-683
|
artikel
|
| 6 |
Axillary reverse mapping for breast cancer
|
Noguchi, Masakuni
|
|
2009
|
119 |
3 |
p. 529-535
|
artikel
|
| 7 |
Characterization of BRCA1 ring finger variants of uncertain significance
|
Sweet, Kevin
|
|
2009
|
119 |
3 |
p. 737-743
|
artikel
|
| 8 |
Derivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approach
|
Sun, Yijun
|
|
2009
|
119 |
3 |
p. 593-599
|
artikel
|
| 9 |
Dietary β-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
|
Nagel, G.
|
|
2009
|
119 |
3 |
p. 753-765
|
artikel
|
| 10 |
Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)
|
Ohashi, Yasuo
|
|
2009
|
119 |
3 |
p. 633-641
|
artikel
|
| 11 |
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy
|
Vo, M. N.
|
|
2008
|
119 |
3 |
p. 767-771
|
artikel
|
| 12 |
Fifteen-year trends in metastatic breast cancer survival in Greece
|
Dafni, U.
|
|
2009
|
119 |
3 |
p. 621-631
|
artikel
|
| 13 |
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
|
Korde, Larissa A.
|
|
2009
|
119 |
3 |
p. 685-699
|
artikel
|
| 14 |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways
|
Buchanan, C.
|
|
2009
|
119 |
3 |
p. 559-574
|
artikel
|
| 15 |
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance
|
Thomas, Nicholas B. P.
|
|
2009
|
119 |
3 |
p. 575-591
|
artikel
|
| 16 |
Impact of menopausal symptoms on quality of life 6 months after systemic breast cancer treatment: results from the Shanghai Breast Cancer Survival Study
|
Dorjgochoo, Tsogzolmaa
|
|
2009
|
119 |
3 |
p. 725-735
|
artikel
|
| 17 |
Loco-regional treatment in metastatic breast cancer patients: Is there a survival benefit?
|
Ly, Bevan H.
|
|
2009
|
119 |
3 |
p. 537-545
|
artikel
|
| 18 |
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial
|
Dranitsaris, George
|
|
2009
|
119 |
3 |
p. 717-724
|
artikel
|
| 19 |
NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics
|
Ostrakhovitch, Elena A.
|
|
2009
|
119 |
3 |
p. 773-786
|
artikel
|
| 20 |
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization
|
Sparano, Joseph A.
|
|
2009
|
119 |
3 |
p. 511-527
|
artikel
|
| 21 |
RETRACTED ARTICLE: Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways
|
Buchanan, C.
|
|
|
119 |
3 |
p. 559-574
|
artikel
|
| 22 |
Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer
|
Fu, De-Yuan
|
|
2009
|
119 |
3 |
p. 601-612
|
artikel
|
| 23 |
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
|
Straver, Marieke E.
|
|
2009
|
119 |
3 |
p. 551-558
|
artikel
|
| 24 |
The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping
|
Hansen, Thomas V. O.
|
|
2009
|
119 |
3 |
p. 547-550
|
artikel
|
| 25 |
Treatment-related symptoms among underserved women with breast cancer: the impact of physician–patient communication
|
Maly, Rose C.
|
|
2009
|
119 |
3 |
p. 707-716
|
artikel
|
| 26 |
Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer
|
Liu, Yihang
|
|
2009
|
119 |
3 |
p. 745-751
|
artikel
|
| 27 |
Women’s decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid
|
Fagerlin, Angela
|
|
2009
|
119 |
3 |
p. 613-620
|
artikel
|
Tijdschrift beschrijving